Published in Antimicrob Agents Chemother on December 01, 1980
Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin. Antimicrob Agents Chemother (1982) 0.98
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
AUTOMATED AND MANUAL DIRECT METHODS FOR THE DETERMINATION OF BLOOD UREA. Clin Chem (1965) 3.74
3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa. J Antibiot (Tokyo) (1971) 2.60
Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J Infect Dis (1978) 1.83
Enzymuria in gentamicin-induced kidney damage. Antimicrob Agents Chemother (1975) 1.72
In vitro comparison of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1978) 1.18
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (2001) 8.53
Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature (1985) 4.23
Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation (1998) 3.99
Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int (2000) 3.86
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest (1999) 3.28
Comparative nephrotoxicities of netilmicin and gentamicin in rats. Antimicrob Agents Chemother (1976) 2.98
Renal parenchymal accumulation of aminoglycoside antibiotics in rats. J Infect Dis (1974) 2.93
Mice with disrupted BK channel beta1 subunit gene feature abnormal Ca(2+) spark/STOC coupling and elevated blood pressure. Circ Res (2000) 2.76
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57
Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension (1986) 2.51
Cardiopulmonary auscultation: duo for strings--Opus 99. Arch Intern Med (1999) 2.26
Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis (1996) 2.22
Posterior fossa neurovascular anomalies in essential hypertension. Lancet (1994) 2.22
Experimental aminoglycoside nephrotoxicity. J Lab Clin Med (1975) 2.19
Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation (1979) 2.15
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension (2000) 2.06
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. Hypertension (2001) 2.04
Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year. Nephrol Dial Transplant (1996) 2.01
Regulation of calcium sparks and spontaneous transient outward currents by RyR3 in arterial vascular smooth muscle cells. Circ Res (2001) 1.88
Effects of multidisciplinary case management in patients with chronic renal insufficiency. Am J Med (1998) 1.86
Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis (1995) 1.85
Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J Infect Dis (1978) 1.83
Enzymuria in gentamicin-induced kidney damage. Antimicrob Agents Chemother (1975) 1.72
Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ Res (2000) 1.71
Overnight urine collections to estimate sodium intake. Hypertension (1983) 1.58
Twin zygosity. Automated determination with microsatellites. J Reprod Med (1997) 1.53
Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med (Berl) (2001) 1.51
Ostial renal artery stent placement for atherosclerotic renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn (1998) 1.50
Time for action. Arch Intern Med (1991) 1.48
Elective stenting of carotid artery stenosis in patients with severe coronary artery disease. Eur Heart J (1998) 1.48
Nephrotoxicity of cephalosporin-gentamicin combinations in rats. Antimicrob Agents Chemother (1976) 1.45
Nontraumatic bilateral rupture of patellar tendons in a diabetic dialysis patient with secondary hyperparathyroidism. Nephrol Dial Transplant (1997) 1.45
A region on chromosome 3 is linked to dizygotic twinning. Nat Genet (2000) 1.44
Adenosquamous carcinoma of the pancreas. Arch Surg (1999) 1.40
Kidneys from pediatric donors: risk versus benefit. Clin Nephrol (1994) 1.39
A left-to-left shunt. Am J Med (1999) 1.38
STOPPING at the CAPPP of good HOPE. Nephrol Dial Transplant (2000) 1.38
Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis (1980) 1.38
Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation (1979) 1.36
Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer (1978) 1.35
A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant (1999) 1.35
Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res (1996) 1.34
Pulmonary fibrosis and nitrofurantoin. Am Rev Respir Dis (1973) 1.34
Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int (1998) 1.34
Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension (1999) 1.30
Correlates of health care satisfaction in inner-city patients with hypertension and chronic renal insufficiency. Soc Sci Med (1995) 1.29
Localization of thiazide-sensitive Na(+)-Cl(-) cotransport and associated gene products in mouse DCT. Am J Physiol Renal Physiol (2001) 1.29
Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension (2001) 1.23
Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet (1996) 1.22
From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model. FASEB J (1997) 1.21
L-type calcium channel expression depends on the differentiated state of vascular smooth muscle cells. FASEB J (1998) 1.20
Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury. Hypertension (2001) 1.19
Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension (1983) 1.19
Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant (1999) 1.19
QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation (1999) 1.18
Pharmacokinetics of cefaclor in normal subjects and patients with chronic renal failure. Antimicrob Agents Chemother (1977) 1.18
Minoxidil treatment of malignant hypertension. Recovery of renal function. JAMA (1978) 1.17
Effects of vancomycin on renal function in rats. Antimicrob Agents Chemother (1981) 1.17
Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc Natl Acad Sci U S A (1996) 1.17
Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clin Pharmacol Ther (1983) 1.16
Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int (1996) 1.15
Protein kinase calpha targeting is regulated by temporal and spatial changes in intracellular free calcium concentration [Ca(2+)](i). FASEB J (2000) 1.13
Anti-endothelial cell antibodies in Takayasu arteritis. Circulation (1996) 1.13
Recovery from aminoglycoside nephrotoxicity with continued drug administration. Antimicrob Agents Chemother (1978) 1.12
Angiotensinogen concentrations and renin clearance : implications for blood pressure regulation. Hypertension (2000) 1.12
K+ currents in human coronary artery vascular smooth muscle cells. Circ Res (1996) 1.12
Hypercalcaemia and sarcoidosis in an anephric dialysis patient. Nephrol Dial Transplant (1994) 1.11
Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome. Clin Nephrol (1978) 1.10
Blood pressure-independent effects in rats with human renin and angiotensinogen genes. Hypertension (2000) 1.10
High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res (1997) 1.10
Relationship between rat renal accumulation of gentamicin, tobramycin, and netilmicin and their nephrotoxicities. Antimicrob Agents Chemother (1985) 1.09
Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function. J Lab Clin Med (1992) 1.08
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. Am J Pathol (2000) 1.08
A pathway model of lipid metabolism to predict the effect of genetic variability on lipid levels. J Mol Med (Berl) (2000) 1.07
Early interstitial changes in hypertension-induced renal injury. Hypertension (1993) 1.07
Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage. Hypertension (2000) 1.07
Aminoglycoside accumulation kinetics in rat renal parenchyma. Antimicrob Agents Chemother (1983) 1.07
Hydrogen peroxide, potassium currents, and membrane potential in human endothelial cells. Circulation (1999) 1.06
Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function. Kidney Int (2001) 1.06
Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. Kidney Int (1999) 1.05
Mezlocillin pharmacokinetics in renal impairment. Clin Pharmacol Ther (1980) 1.05
Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis (1998) 1.04
Intra- and interindividual variability in sodium intake in normal subjects and in patients with renal insufficiency. Am J Kidney Dis (1986) 1.04
beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension (1999) 1.03
Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor. Circulation (2001) 1.03
Medical compared with surgical treatment for massive pulmonary embolism. Lancet (1994) 1.03
Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. Kidney Int (2000) 1.03
Effect of gentamicin on glomerular ultrastructure. J Lab Clin Med (1981) 1.03
Comparative nephrotoxicity of SCH 21420 and amikacin in rats. Antimicrob Agents Chemother (1979) 1.02